companyname: Symbiotec Pharmalab Limited ticker: TL2320 sector: Pharmaceuticals / Active Pharmaceutical Ingredients (API) documenttype: IPO Research Report Symbiotec Pharmalab Limited is raising a total of ₹17,570.00 million through this IPO. The offer splits into two parts: a fresh issue of up to ₹1,500.00 million that goes to the company, and an offer for sale of up to ₹16,070.00 million that goes entirely to three selling shareholders. The company receives roughly 8.5% of the total offer pro...
Read the full report →Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Symbiotec Pharmalab and 4,900+ companies.
5-day free pass. No card required.